Arcadia Biosciences, Inc.
RKDA
$3.46
$0.20196.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.04M | -5.83M | -6.78M | -7.02M | -13.98M |
| Total Depreciation and Amortization | 765.00K | 816.00K | 926.00K | 961.00K | 984.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.91M | -4.37M | -4.52M | -4.99M | 1.21M |
| Change in Net Operating Assets | -1.45M | -2.18M | -2.33M | -3.99M | -3.51M |
| Cash from Operations | -9.63M | -11.56M | -12.70M | -15.04M | -15.29M |
| Capital Expenditure | -16.00K | -16.00K | -16.00K | -18.00K | -5.00K |
| Sale of Property, Plant, and Equipment | 334.00K | 415.00K | 240.00K | 102.00K | 115.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.02M | 4.48M | 4.48M | -4.74M | -4.45M |
| Cash from Investing | 7.34M | 4.88M | 4.70M | -4.66M | -4.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00K | 9.00K | 12.00K | 12.00K | 6.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -497.00K |
| Cash from Financing | 9.00K | 9.00K | 12.00K | 12.00K | 5.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.28M | -6.68M | -7.98M | -19.68M | -14.13M |